Skip to main content

BFSG, LLC

SEC CIK
0001706836
Latest filing
Jul 20, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by BFSG, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
12,243
Value
$586.9K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by BFSG, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,243$586.9K0.1%−36,936−75.1%ReducedHolders
Q1 202649,179$1.81M0.2%−111−0.2%ReducedHolders
Q4 202549,290$2.51M0.2%−74,674−60.2%ReducedHolders
Q3 2025123,964$6.88M0.7%+6,514+5.5%AddedHolders
Q2 2025117,450$8.11M0.9%+1,943+1.7%AddedHolders
Q1 2025115,507$8.02M1.0%+12,515+12.2%AddedHolders
Q4 2024102,992$8.86M1.0%+16,375+18.9%AddedHolders
Q3 202486,617$10.3M1.2%+42,662+97.1%AddedHolders
Q2 202443,955$6.27M0.8%−2,590−5.6%ReducedHolders
Q1 202446,545$5.98M0.8%−209−0.4%ReducedHolders
Q4 202346,754$4.84M0.7%+36+0.1%AddedHolders
Q3 202346,718$4.25M0.7%+3,278+7.5%AddedConverted for a 2-for-1 splitHolders
Q2 202321,720$3.52M0.6%+3,282+17.8%AddedHolders
Q1 202318,438$2.93M0.5%−30−0.2%ReducedHolders
Q4 202218,468$2.50M0.5%−425−2.2%ReducedHolders
Q3 202218,893$1.88M0.4%−430−2.2%ReducedHolders
Q2 202219,323$2.15M0.4%−254−1.3%ReducedHolders
Q1 202219,577$2.17M0.3%−894−4.4%ReducedHolders
Q4 202120,471$2.29M0.3%−1,155−5.3%ReducedHolders
Q3 202121,626$2.08M0.3%−335−1.5%ReducedHolders
Q2 202121,961$1.84M0.3%−1,093−4.7%ReducedHolders
Q1 202123,054$1.55M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.